First Time Loading...

Replimune Group Inc
NASDAQ:REPL

Watchlist Manager
Replimune Group Inc Logo
Replimune Group Inc
NASDAQ:REPL
Watchlist
Price: 5.27 USD 3.33% Market Closed
Updated: Jun 1, 2024

Replimune Group Inc
Short-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Replimune Group Inc
Short-Term Investments Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Short-Term Investments Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Replimune Group Inc
NASDAQ:REPL
Short-Term Investments
$346.2m
CAGR 3-Years
6%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Short-Term Investments
$2m
CAGR 3-Years
-55%
CAGR 5-Years
-64%
CAGR 10-Years
-46%
Gilead Sciences Inc
NASDAQ:GILD
Short-Term Investments
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Short-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Short-Term Investments
$1B
CAGR 3-Years
18%
CAGR 5-Years
12%
CAGR 10-Years
1%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Short-Term Investments
$7.9B
CAGR 3-Years
56%
CAGR 5-Years
39%
CAGR 10-Years
46%

See Also

What is Replimune Group Inc's Short-Term Investments?
Short-Term Investments
346.2m USD

Based on the financial report for Mar 31, 2024, Replimune Group Inc's Short-Term Investments amounts to 346.2m USD.

What is Replimune Group Inc's Short-Term Investments growth rate?
Short-Term Investments CAGR 5Y
26%

Over the last year, the Short-Term Investments growth was -21%. The average annual Short-Term Investments growth rates for Replimune Group Inc have been 6% over the past three years , 26% over the past five years .